|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Contract receivables | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Contract receivables from related parties | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Long-Term Assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Right-of-use operating lease assets, net | ||||||||||||||||||||
| Right-of-use finance lease assets, net | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Loan receivable from equity method investee | ||||||||||||||||||||
| Total long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, Mezzanine Equity and Stockholders' Equity | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable and other accrued liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Deferred revenue from related parties | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-Term Liabilities | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Mezzanine Equity | ||||||||||||||||||||
| Mezzanine Equity | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Common Stock, $0.0001 par value; 2,000,000,000 shares authorized; 227,217,240 and 201,181,175 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total common Stock, $0.0001 par value; 2,000,000,000 shares authorized; 227,217,240 and 201,181,175 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities, mezzanine equity and stockholders' equity | ||||||||||||||||||||
Loading...